BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

EMA grants Orphan Drug Designation to GC Biopharma's Sanfilippo Syndrome (Type A) Treatment

GC1130A has previously achieved notable milestones by securing both Rare Pediatric Disease designation (RPDD) and Orphan Drug Designation (ODD) from the U....

January 24, 2024 | News

Lunit AI to Enhance Samsung's X-ray Devices for Chest Screening

Three-year supply contract: Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage to enhance lung abnormality detection in Samsung's premium X-ray devices &nbs...

January 17, 2024 | News

FUST Lab's DEBREX Nano-Emulsion Equipment Launches in Japan

Dispersion/emulsification technology (technology for mixing two or more immiscible substances) is a key technology used in various productions such as cosm...

January 16, 2024 | News

Lotte Biologics Unveils Songdo Bio Plant Development Plan at JPM Healthcare Conference 2024

Richard Lee, CEO of LOTTE BIOLOGICS, delivers a keynote speech at the JPM Healthcare Conference for the second consecutive year Unveils company's b...

January 11, 2024 | News

GC Cell Initiates Phase 1 Trials for AB-201 Cancer Treatment with Lunit AI Platform

GC Cell, a fully integrated cell therapy pioneer, is proud to announce the approval from both the Australian Human Research Ethics Committee (HREC) a...

January 09, 2024 | News

Health On Cloud Goes Global with Metaverse Medical Platform

This expansion is scheduled to launch in Kazakhstan, Colombia, and several other Latin American countries in 2024, marking a strategic move that ...

January 02, 2024 | News

TiumBio Raises KRW 38.5B for Upcoming Clinical Data

The proceeds will fund its robust clinical programs and bolster TiumBio's financial position. Data read-outs from a Phase 2 trial of merigolix...

January 01, 2024 | News

Dx&Vx Partners with LG CNS to Develop Bio-Health Data Platform in South Korea

Dx&Vx recently announced on the 18th that it has signed a contract with LG CNS to jointly develop a bio-healthcare big data platform utilizing AI ...

December 21, 2023 | News

GC Biopharma's ALYGLO™ 10% Liquid FDA Approved for Adult Primary Immunodeficiency.

The ALYGLO pivotal phase 3 clinical study followed FDA guidance for the treatment of patients with PI. The clinical trial (NCT02783482) GC5107B was a prosp...

December 18, 2023 | News

Lunit Secures Acquisition of Volpara: Agreement on Scheme Implementation Established

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced its proposal to acquire Volpara Health...

December 15, 2023 | News

Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection

- A large population-based retrospective study in Denmark validates that Lunit INSIGHT MMG's accuracy is on par with tha...

November 27, 2023 | News

DxVx Plans License-In of OVM-200, Launches Clinical Trials in Asia

Final stage in licensing OVM-200 from Oxford Vacmedix in the UK- DxVx plans to proceed its own clinical trials in Asia, including Korea and Chi...

November 27, 2023 | News

PharmAbcine Reveals PMC-403 Potential in Idiopathic Systemic Capillary Leak Syndrome Models

The results underscore the novel mechanism of action, demonstrating the ability of PMC-403 to reduce vascular leakage associated with ISCLS in the preclini...

November 23, 2023 | News

SK Bioscience and Hilleman Labs Collaborate on Next-Gen Ebola Vaccine

SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entere...

November 22, 2023 | News

Stay Connected